| Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: a 2013 follow-up study M Berruyer, C Tanguay, NJ Caron, M Lefebvre, JF Bussières Journal of occupational and environmental hygiene 12 (2), 87-94, 2015 | 57 | 2015 |
| Closed‐system drug‐transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff KS Gurusamy, LMJ Best, C Tanguay, E Lennan, M Korva, JF Bussières Cochrane Database of Systematic Reviews, 2018 | 56 | 2018 |
| Surface contamination with ten antineoplastic drugs in 83 Canadian centers L Chauchat, C Tanguay, NJ Caron, S Gagné, F Labrèche, JF Bussières Journal of Oncology Pharmacy Practice 25 (5), 1089-1098, 2019 | 51 | 2019 |
| Environmental contamination with hazardous drugs in Quebec hospitals JF Bussières, C Tanguay, K Touzin, É Langlois, M Lefebvre The Canadian Journal of Hospital Pharmacy 65 (6), 428, 2012 | 48 | 2012 |
| Environmental contamination with cyclophosphamide, ifosfamide, and methotrexate: a study of 51 Canadian centres A Janes, C Tanguay, NJ Caron, JF Bussières The Canadian journal of hospital pharmacy 68 (4), 279, 2015 | 45 | 2015 |
| Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals D Merger, C Tanguay, E Langlois, M Lefebvre, JF Bussières International archives of occupational and environmental health 87, 307-313, 2014 | 45 | 2014 |
| Depletion of RNase HI activity in Escherichia coli lacking DNA topoisomerase I leads to defects in DNA supercoiling and segregation V Usongo, F Nolent, P Sanscartier, C Tanguay, S Broccoli, I Baaklini, ... Molecular microbiology 69 (4), 968-981, 2008 | 35 | 2008 |
| Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals C Poupeau, C Tanguay, NJ Caron, JF Bussières Journal of Oncology Pharmacy Practice 24 (1), 9-17, 2018 | 34 | 2018 |
| Interplay between type 1A topoisomerases and gyrase in chromosome segregation in Escherichia coli V Usongo, C Tanguay, F Nolent, JE Bessong, M Drolet Journal of bacteriology 195 (8), 1758-1768, 2013 | 24 | 2013 |
| Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers C Poupeau, C Tanguay, C Plante, S Gagné, N Caron, JF Bussières Journal of Oncology Pharmacy Practice 23 (5), 323-332, 2017 | 23 | 2017 |
| External contamination of commercial containers by antineoplastic agents: a literature review D Hilliquin, C Tanguay, JF Bussières European Journal of Hospital Pharmacy 27 (5), 313-314, 2020 | 18 | 2020 |
| Evaluation of decontamination strategies for cyclophosphamide A Soubieux, M Palamini, C Tanguay, JF Bussières Journal of Oncology Pharmacy Practice 26 (2), 413-422, 2020 | 16 | 2020 |
| Perspective québécoise et canadienne de la pratique pharmaceutique en établissement de santé 2009–2010 JF Bussières, C Tanguay, P Lefebvre Pharmactuel 44 (2), 122-152, 2011 | 15* | 2011 |
| Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program C Chabut, C Tanguay, S Gagné, N Caron, JF Bussières Journal of Oncology Pharmacy Practice 28 (2), 343-352, 2022 | 14 | 2022 |
| Environmental contamination with methotrexate in Canadian community pharmacies. D Merger, C Tanguay, É Langlois, M Lefebvre, JF Bussières Journal of the American Pharmacists Association: JAPhA 53 (4), 423-426, 2013 | 13 | 2013 |
| Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers C Delafoy, C Roussy, AF Hudon, CM Cirtiu, N Caron, JF Bussières, ... Journal of Oncology Pharmacy Practice 29 (2), 338-347, 2023 | 12 | 2023 |
| Projet Impact Pharmacie sur la description du rôle et sur les retombées du pharmacien: méthodologie A Guérin, I Barthélémy, D Merger, C Tanguay, D Lebel, JF Bussières Annales de l’Unité de recherche en pratique pharmaceutique 30, 1-8, 2014 | 9 | 2014 |
| Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices A Soubieux, C Tanguay, JF Bussières European Journal of Hospital Pharmacy 28 (2), 65-70, 2021 | 8 | 2021 |
| Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs A Soubieux, C Tanguay, J Lachaine, JF Bussières European Journal of Hospital Pharmacy 27 (6), 361-366, 2020 | 8 | 2020 |
| Perspective québécoise et canadienne de la pratique pharmaceutique en établissement de santé pour 2016-2017 JF Bussières, C Tanguay, A Bonnici Pharmactuel 51 (2), 105-142, 2018 | 8 | 2018 |
Jean-François BussièresPharmacien, responsable URPP, CHU Sainte-Justine; professeur titulaire de clinique, U de MVerified email at umontreal.ca
